Next generation advanced RNA inhibition therapy to treat cardiometabolic disease (LiverTarget)

Principal Investigators:

• GIULIA MARIA CAROLA CHIESA

Financing institution:

EUROPEAN COMMISSION

Type:

Horizon Europe Global Challenge-RIA/IA/CSA

Project leader:

TAMPEREEN KORKEAKOULUSAATIO SR

Year:

2022

Duration:

60

Status:

Ongoing